ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.053 AUD -1.85% Market Closed
Market Cap: 107.2m AUD
Have any thoughts about
ImpediMed Ltd?
Write Note

ImpediMed Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ImpediMed Ltd
Capital Expenditures Peer Comparison

Comparables:
R
RSH
C
CYC
COH
OIL
EMV

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
ImpediMed Ltd
ASX:IPD
Capital Expenditures
-AU$3.1m
CAGR 3-Years
-8%
CAGR 5-Years
-7%
CAGR 10-Years
-59%
R
Respiri Ltd
ASX:RSH
Capital Expenditures
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cyclopharm Ltd
ASX:CYC
Capital Expenditures
-AU$905.5k
CAGR 3-Years
-21%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Cochlear Ltd
ASX:COH
Capital Expenditures
-AU$89.8m
CAGR 3-Years
-10%
CAGR 5-Years
5%
CAGR 10-Years
-11%
Optiscan Imaging Ltd
ASX:OIL
Capital Expenditures
-AU$87.4k
CAGR 3-Years
-41%
CAGR 5-Years
-81%
CAGR 10-Years
N/A
EMvision Medical Devices Ltd
ASX:EMV
Capital Expenditures
-AU$302.4k
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ImpediMed Ltd's Capital Expenditures?
Capital Expenditures
-3.1m AUD

Based on the financial report for Jun 30, 2024, ImpediMed Ltd's Capital Expenditures amounts to -3.1m AUD.

What is ImpediMed Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-59%

Over the last year, the Capital Expenditures growth was 49%. The average annual Capital Expenditures growth rates for ImpediMed Ltd have been -8% over the past three years , -7% over the past five years , and -59% over the past ten years .

Back to Top